semaglutide cardiac Long-Term SELECT Trial: Cuts Cardiovascular Events by 20% beyond Weight Loss Semaglutide protects heart beyond weight

In particular, sDPP-4 acts as a direct mediator of endothelial dysfunction, probably through PAR2 activation and the induction of vasoconstrictor prostanoid release (e.g., thromboxane A2) [60]

Berberine should not be described as a GLP-1 'activator' in the medicinal sense, as any effects on GLP-1 pathways appear to be indirect and considerably less potent than pharmaceutical GLP-1 therapies

[00:07:29] Dr

doi: 10.1016/j.mce.2008.11.018

The development of novel dual- or triple-receptor agonists that bind to the receptors not only for GLP-1 but also to the receptors for glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon is intended to address different metabolic pathways for carbohydrate, lipid, and protein metabolism simultaneously